Navigation Links
MAP Pharmaceuticals to Present at Upcoming Investor Conferences
Date:8/9/2012

MOUNTAIN VIEW, Calif., Aug. 9, 2012 /PRNewswire/ -- MAP Pharmaceuticals, Inc. (Nasdaq: MAPP) today announced that the Company will present at the following investor conferences:

Canaccord Genuity 32nd Annual Growth Conference
Thursday, August 16, at 11:30 a.m. ET in Boston

Stifel Nicolaus Annual Healthcare Conference
Thursday, September 6, at 8:00 a.m. ET in Boston

A live webcast of each presentation will be available on the Investor Relations section of MAP Pharmaceuticals' website at http://www.mappharma.com. A replay also will be available within 24 hours for seven days following each presentation.

About MAP Pharmaceuticals

MAP Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing new therapies to address undermet patient needs in neurology. The Company is developing LEVADEX®, an orally inhaled investigational drug for the acute treatment of migraine. The U.S. Food and Drug Administration (FDA) reviewed the New Drug Application (NDA) for LEVADEX and on March 26, 2012, the Company received a Complete Response letter with respect to this NDA. The Company completed an End-of-Review meeting with the FDA and plans to resubmit in the late third quarter/early fourth quarter 2012 timeframe. MAP Pharmaceuticals has entered into a collaboration agreement with Allergan, Inc. to co-promote LEVADEX to neurologists and pain specialists in the U.S. and Canada. The Company also applies its proprietary drug particle and inhalation technologies to generate new pipeline opportunities by enhancing the therapeutic benefits of proven drugs, while minimizing risk by capitalizing on their known safety, efficacy and commercialization history. Additional information about MAP Pharmaceuticals can be found at http://www.mappharma.com.

CONTACT:
Lisa Borland
MAP Pharmaceuticals, Inc.
650-386-3122
lborland@mappharma.com


'/>"/>
SOURCE MAP Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Avanir Pharmaceuticals Reports Fiscal 2012 Third Quarter Financial And Business Results
2. Savient Pharmaceuticals Reports Second Quarter 2012 Financial Results
3. Auxilium Pharmaceuticals, Inc. to Present at the Canaccord Genuity 32nd Annual Growth Conference
4. UCF nanoparticle discovery opens door for pharmaceuticals
5. Cadence Pharmaceuticals Reports Second Quarter 2012 Financial Results
6. Inspiration Biopharmaceuticals Expands Industry Expertise with Five New Executive Hires
7. Optimer Pharmaceuticals Reports Second Quarter 2012 Financial Results
8. MAP Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock
9. Global Biopharmaceuticals Market 2011-2015
10. Patient Advocate Foundation and Jazz Pharmaceuticals Announce Partnership for Narcolepsy CareLine
11. Convergence Pharmaceuticals Announces Successful Completion of Phase I for CNV2197944 and Plans Phase II Studies in Neuropathic Pain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/26/2017)... ... 2017 , ... The leading Regenerative Veterinary Medicine Company, ... has been used on more than 13,000 animals. VetStem was founded in ... to tendons and ligaments. , In 2003 VetStem signed a worldwide exclusive license ...
(Date:7/26/2017)... Jacksonville, FL (PRWEB) , ... July 26, 2017 ... ... deep learning algorithms targeted towards leveraging the years of diagnostic excellence by Mayo ... Logix. The first product suite will be distributed through the Microsoft Azure ...
(Date:7/25/2017)... ... 2017 , ... Fiberstar, Inc ., a global market leader in clean ... natural citrus fiber is used to improve tomato-based food products by replacing starches and ... spreads. Today, more than ever, consumers connect ingredients to the foods they eat by ...
(Date:7/24/2017)... -- Intralytix, Inc. announced that it received $17.5 million ... group. This investment marks the beginning of a close ... products, for various benefits in human health and in ... As a global key player in ... solutions for baking, food taste & pleasure, health care, ...
Breaking Biology Technology:
(Date:3/22/2017)...   Neurotechnology , a provider of high-precision ... the release of the SentiVeillance 6.0 ... recognition using up to 10 surveillance, security and ... new version uses deep neural-network-based facial detection and ... a Graphing Processing Unit (GPU) for enhanced speed. ...
(Date:3/22/2017)... LIVERMORE, Calif. , March 21, 2017 ... recognition analytics company serving law enforcement agencies, announced today ... Sheridan as director of public safety business development. ... of diversified law enforcement experience, including a focus on ... Vigilant. In his most recent position, Mr. Sheridan served ...
(Date:3/20/2017)... PMD Healthcare announces the release of its ... System (WMS), a remote, real-time lung health monitoring and ... is a Medical Device, Digital Health, and Chronic Care ... innovative solutions that empower people to improve their healthcare ... developed the first ever personal spirometer, Spiro PD, which ...
Breaking Biology News(10 mins):